Pascal and Francis Bibliographic Databases


Search results

Your search

kw.\*:("Immunological adjuvant")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV


A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 3820

  • Page / 153

Selection :

  • and

Alum adjuvant: some of the tricks of the oldest adjuvant : Vaccines and AdjuvantsKOOL, Mirjam; FIERENS, Kaat; LAMBRECHT, Bart N et al.Journal of medical microbiology. 2012, Vol 61, Num 7, pp 927-934, issn 0022-2615, 8 p.Conference Paper

The effect of Freund's adjuvants on blood-cerebrospinal fluid barrier permeabilityREIBER, H; SUCKLING, A. J; RUMSBY, M. G et al.Journal of the neurological sciences. 1984, Vol 63, Num 1, pp 55-61, issn 0022-510XArticle

The choice of adjuvants in Mycoplasma vaccinesGARBA, S. A; TERRY, R. J; ADEGBOYE, D. S et al.Microbios. 1989, Vol 57, Num 230, pp 15-19, issn 0026-2633, 5 p.Article

Comparative adjuvant activities of Legionella pneumophila and Mycobacterium tuberculosisMCMASTER, P. R. B; TSANG, V. C. W; WONG, K. H et al.International archives of allergy and applied immunology. 1984, Vol 73, Num 4, pp 357-362, issn 0020-5915Article

Safety of MFS9™ adjuvantSCHULTZE, Viola; D'AGOSTO, Vicente; WACK, Andreas et al.Vaccine. 2008, Vol 26, Num 26, pp 3209-3222, issn 0264-410X, 14 p.Article

Adjuvants and delivery systems in veterinary vaccinology: current state and future developmentsHEEGAARD, Peter M. H; DEDIEU, Laurence; JOHNSON, Nicholas et al.Archives of virology. 2011, Vol 156, Num 2, pp 183-202, issn 0304-8608, 20 p.Article

Vaccine with herbal adjuvant-A better cocktail to combat the infectionSAKURE, Sandhya; VIDYA DEVI NEGI; SHANKAR KUMAR MITRA et al.Vaccine. 2008, Vol 26, Num 27-28, pp 3387-3388, issn 0264-410X, 2 p.Article

Non-toxic derivatives of LT as potent adjuvantsDA HORA, Vanusa P; CONCEICAO, Fabricio R; DELLAGOSTIN, Odir A et al.Vaccine. 2011, Vol 29, Num 8, pp 1538-1544, issn 0264-410X, 7 p.Article

The adjuvant effect of di-(2-ethylhexyl) phthalate is mediated through a PPARα-independent mechanismLARSEN, Søren Thor; NIELSEN, Gunnar Damgard.Toxicology letters. 2007, Vol 170, Num 3, pp 223-228, issn 0378-4274, 6 p.Article

Evaluation of widely consumed botanicals as immunological adjuvantsRAGUPATHI, Govind; YEUNG, K. Simon; LIVINGSTON, Philip et al.Vaccine. 2008, Vol 26, Num 37, pp 4860-4865, issn 0264-410X, 6 p.Article

Disparate adjuvant properties among three formulations of alumCAIN, Derek W; SANDERS, Sergio E; CUNNINGHAM, Michael M et al.Vaccine. 2013, Vol 31, Num 4, pp 653-660, issn 0264-410X, 8 p.Article

Co-stimulatory agonists as immunological adjuvantsBARR, Tom A; CARLRING, Jennifer; HEATH, Andrew W et al.Vaccine. 2006, Vol 24, Num 17, pp 3399-3407, issn 0264-410X, 9 p.Article

European union regulatory developments for new vaccine adjuvants and delivery systemsSESARDIC, Dorothea; DOBBELAER, Roland.Vaccine. 2004, Vol 22, Num 19, pp 2452-2456, issn 0264-410X, 5 p.Conference Paper

VACCINS Les adjuvants en renfort ! = Vaccins and adjuvants for enhancing immunityLARGETEAU, Quitterie.Découverte (Paris. 1999). 2012, Num 383, pp 26-35, issn 1621-0085, 10 p.Article

Preformulation studies—The next advance in aluminum adjuvant-containing vaccinesHEM, Stanley L; HOGENESCH, Harm; MIDDAUGH, C. Russell et al.Vaccine. 2010, Vol 28, Num 31, pp 4868-4870, issn 0264-410X, 3 p.Article

The use of propolis as vaccine's adjuvantEL ASHRY, El Sayed H; AHMAD, Tarek A.Vaccine. 2012, Vol 31, Num 1, pp 31-39, issn 0264-410X, 9 p.Article

Adjuvant potential of aggregate-forming polyglutamine domainsILYINSKII, P. O; THOIDIS, G; SHERMAN, M. Y et al.Vaccine. 2008, Vol 26, Num 26, pp 3223-3226, issn 0264-410X, 4 p.Article

A kinetic study of histopathological changes in the subcutis of cats injected with non-adjuvanted and adjuvanted multi-component vaccinesDAY, M. J; SCHOON, H.-A; POLLMEIER, M et al.Vaccine. 2007, Vol 25, Num 20, pp 4073-4084, issn 0264-410X, 12 p.Article

Inclusion of CpG adjuvant with plasmid DNA coding for NcGRA7 improves protection against congenital neosporosisJENKINS, Mark; PARKER, Carolyn; WENBIN TUO et al.Infection and immunity. 2004, Vol 72, Num 3, pp 1817-1819, issn 0019-9567, 3 p.Article

The aluminum content of biological products containing aluminum adjuvants: determination by atomic absorption spectrometryMAY, J. C; PROGAR, J. J; CHIN, R et al.Journal of biological standardization. 1984, Vol 12, Num 2, pp 175-183, issn 0092-1157Article

Vaccine AdjuvantsREED, Steven G.Expert review of vaccines. 2013, Vol 12, Num 7, issn 1476-0584, [112 p.]Serial Issue

ISCOMATRIX: a novel adjuvant for use in prophylactic and therapeutic vaccines against infectious diseases : Vaccines and AdjuvantsBAZ MORELLI, Adriana; BECHER, Dorit; KOERNIG, Sandra et al.Journal of medical microbiology. 2012, Vol 61, Num 7, pp 935-943, issn 0022-2615, 9 p.Conference Paper

The safety evaluation of adjuvants during vaccine development: The AS04 experienceGARCON, Nathalie; SEGAL, Lawrence; TAVARES, Fernanda et al.Vaccine. 2011, Vol 29, Num 27, pp 4453-4459, issn 0264-410X, 7 p.Article

Adjuvant Host-Directed Therapy with Types 3 and 5 but Not Type 4 Phosphodiesterase Inhibitors Shortens the Duration of Tuberculosis TreatmentMAIGA, Mamoudou; AMMERMAN, Nicole C; MAIGA, Mariama C et al.The Journal of infectious diseases. 2013, Vol 208, Num 3, pp 512-519, issn 0022-1899, 8 p.Article

Imject® Alum is not aluminum hydroxide adjuvant or aluminum phosphate adjuvantHEM, Stanley L; JOHNSON, Cliff T; HOGENESCH, H Arm et al.Vaccine. 2007, Vol 25, Num 27, pp 4985-4986, issn 0264-410X, 2 p.Article

  • Page / 153